 | Up a level |
2017
Feiterna-Sperling, C., Brinkmann, F., Adamczick, C., Ahrens, F., Barker, M., Berger, C., Berthold, L. D., Bogyi, M., von Both, U., Frischer, T., Haas, W., Hartmann, P., Hillemann, D., Hirsch, F. W., Kranzer, K., Kunitz, F., Maritz, E., Pizzulli, A., Ritz, N., Schlags, R., Spindler, T., Thee, S. and Weizsaecker, K. (2017). Consensus-Based Guidelines for Diagnosis, Prevention and Treatment of Tuberculosis in Children and Adolescents. Pneumologie, 71 (10). S. 629 - 681. STUTTGART: GEORG THIEME VERLAG KG. ISSN 1438-8790
Nowag, A., Platten, M., Plum, G. and Hartmann, P. (2017). Nontuberculous mycobacterial infections. Z. Rheumatol., 76 (9). S. 752 - 761. HEIDELBERG: SPRINGER HEIDELBERG. ISSN 1435-1250
2016
Fischer, J., Cassens, J., Gutierrez, S., Venkatesh, R., Daglidu, E., Hos, N., Stepek, J., Hartmann, P., Bruening, J. and Robinson, N. (2016). Leptin-receptor signaling regulates Salmonella Typhimurium induced inflammatory responses. Internist, 57. S. S34 - 2. NEW YORK: SPRINGER. ISSN 1432-1289
Nowag, A. and Hartmann, P. (2016). Immune response to Mycobacterium tuberculosis. Internist, 57 (2). S. 107 - 116. NEW YORK: SPRINGER. ISSN 1432-1289
Stephan, A., Batinica, M., Steiger, J., Hartmann, P., Zaucke, F., Bloch, W. and Fabri, M. (2016). LL37:DNA complexes provide antimicrobial activity against intracellular bacteria in human macrophages. J. Invest. Dermatol., 136 (9). S. S215 - 1. NEW YORK: ELSEVIER SCIENCE INC. ISSN 1523-1747
2015
Nowag, A., Mauer, J., Winter, S., Odenthal, M., Bruening, J. and Hartmann, P. (2015). Diabetes and mycobacterial Infections - an ominous Alliance - Studies on the Role of Insulin Signal -Transduction and metabolic Changes in the Immune response against M. avium. Internist, 56. S. 17 - 18. NEW YORK: SPRINGER. ISSN 1432-1289
Nowag, A., Mauer, J., Winter, S., Odenthal, M., Bruening, J. and Hartmann, P. (2015). Diabetes and mycobacterial Infections - an ominous Alliance - Studies on the Role of Insulin Signal -Transduction and metabolic Changes in the Immune response against M. avium. Internist, 56. S. 17 - 18. NEW YORK: SPRINGER. ISSN 1432-1289
2014
Langerbeins, P., Busch, R., Schweighofer, C. D., Mueller, C., Cramer, P., Fink, A. M., Faetkenheuer, G., Hartmann, P., Stilgenbauer, S., Boettcher, S., Wendtner, C. M., Hallek, M. and Eichhorst, B. (2014). SEVERE INFECTIONS ARE MORE COMMON IN PHYSICALLY FIT CLL PATIENTS WITH FCR-THERAPY COMPARED TO BR: RESULTS OF THE INTERMIN-ANALYSIS OF THE CLL10 TRIAL OF THE GERMAN CLL STUDY GROUP. Haematologica, 99. S. 55 - 57. PAVIA: FERRATA STORTI FOUNDATION. ISSN 0390-6078
Langerbeins, P., Busch, R., Schweighofer, C. D., Mueller, C., Fischer, K., Fink, A. -M., Cramer, P., Faetkenheuer, G., Hartmann, P., Stilgenbauer, S., Boettcher, S., Wendtner, C. -M., Hallek, M. and Eichhorst, B. (2014). More severe infectious complications in CLL patients treated with fludarabine, cyclophosphamide, rituximab (FCR) in comparison to bendamustin plus rituximab (BR): Results of the interim-analysis of the CLL10 trial of the German CLL Study Group. Oncol. Res. Treat., 37. S. 185 - 186. BASEL: KARGER. ISSN 2296-5262
2013
Vehreschild, J. J., Morgen, G., Cornely, O. A., Hartmann, P., Koch, S., Kalka-Moll, W., Wyen, C., Vehreschild, M. J. G. T., Lehmann, C., Gillor, D., Seifert, H., Kremer, G., Faetkenheuer, G. and Jung, N. (2013). Evaluation of an infectious disease consultation programme in a German tertiary care hospital. Infection, 41 (6). S. 1121 - 1129. HEIDELBERG: SPRINGER HEIDELBERG. ISSN 1439-0973